Yangsong Xu , Man K.S. Lee , Nicole A. de Weerd , Ziyue Fu , Camilla Bertuzzo Veiga , Dragana Dragoljevic , Dmitri Sviridov , Paul J. Hertzog , Andrew J. Fleetwood , Andrew J. Murphy
{"title":"Type I interferon signaling controls the early hematopoietic expansion in response to β-glucan","authors":"Yangsong Xu , Man K.S. Lee , Nicole A. de Weerd , Ziyue Fu , Camilla Bertuzzo Veiga , Dragana Dragoljevic , Dmitri Sviridov , Paul J. Hertzog , Andrew J. Fleetwood , Andrew J. Murphy","doi":"10.1016/j.isci.2025.112347","DOIUrl":null,"url":null,"abstract":"<div><div>Rapid hematopoietic adaptations are important for building and sustaining the biological response to β-glucan. The signals involved in these early events have not yet been fully explored. Given that type I interferons are produced in response to β-glucan and can profoundly impact hematopoietic stem cell (HSC) function, we hypothesized that this pathway may be involved in the early bone marrow response to β-glucan. <em>In vivo</em> administration of β-glucan led to local interferon-α production in the peritoneal cavity and bone marrow, upregulation of its receptor, IFNAR1, specifically on long-term hematopoietic stem cells (LT-HSCs), and broad expansion of downstream progenitor subpopulations. We demonstrate that intact type I interferon signaling is critical for β-glucan-mediated LT-HSC proliferation, mitochondrial activity, and glycolytic commitment. By determining that type I interferon signaling is important for LT-HSCs, which sit at the apex of the hematopoietic hierarchy, we uncover an important component of the early inflammatory response to β-glucan.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"28 5","pages":"Article 112347"},"PeriodicalIF":4.6000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"iScience","FirstCategoryId":"103","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S258900422500608X","RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Rapid hematopoietic adaptations are important for building and sustaining the biological response to β-glucan. The signals involved in these early events have not yet been fully explored. Given that type I interferons are produced in response to β-glucan and can profoundly impact hematopoietic stem cell (HSC) function, we hypothesized that this pathway may be involved in the early bone marrow response to β-glucan. In vivo administration of β-glucan led to local interferon-α production in the peritoneal cavity and bone marrow, upregulation of its receptor, IFNAR1, specifically on long-term hematopoietic stem cells (LT-HSCs), and broad expansion of downstream progenitor subpopulations. We demonstrate that intact type I interferon signaling is critical for β-glucan-mediated LT-HSC proliferation, mitochondrial activity, and glycolytic commitment. By determining that type I interferon signaling is important for LT-HSCs, which sit at the apex of the hematopoietic hierarchy, we uncover an important component of the early inflammatory response to β-glucan.
快速造血适应对于建立和维持对β-葡聚糖的生物反应非常重要。这些早期事件所涉及的信号尚未得到充分探究。鉴于I型干扰素是针对β-葡聚糖产生的,并能深刻影响造血干细胞(HSC)的功能,我们推测这一途径可能参与了骨髓对β-葡聚糖的早期反应。体内给予β-葡聚糖会导致腹腔和骨髓产生局部干扰素-α,其受体IFNAR1上调,特别是在长期造血干细胞(LT-HSCs)上,以及下游祖细胞亚群的广泛扩增。我们证明,完整的I型干扰素信号传导对β-葡聚糖介导的LT-造血干细胞增殖、线粒体活性和糖酵解承诺至关重要。通过确定 I 型干扰素信号对处于造血系统顶端的 LT-HSCs 的重要性,我们发现了早期炎症反应中对β-葡聚糖的一个重要组成部分。
期刊介绍:
Science has many big remaining questions. To address them, we will need to work collaboratively and across disciplines. The goal of iScience is to help fuel that type of interdisciplinary thinking. iScience is a new open-access journal from Cell Press that provides a platform for original research in the life, physical, and earth sciences. The primary criterion for publication in iScience is a significant contribution to a relevant field combined with robust results and underlying methodology. The advances appearing in iScience include both fundamental and applied investigations across this interdisciplinary range of topic areas. To support transparency in scientific investigation, we are happy to consider replication studies and papers that describe negative results.
We know you want your work to be published quickly and to be widely visible within your community and beyond. With the strong international reputation of Cell Press behind it, publication in iScience will help your work garner the attention and recognition it merits. Like all Cell Press journals, iScience prioritizes rapid publication. Our editorial team pays special attention to high-quality author service and to efficient, clear-cut decisions based on the information available within the manuscript. iScience taps into the expertise across Cell Press journals and selected partners to inform our editorial decisions and help publish your science in a timely and seamless way.